Over the course of this year, Halberd Corporation (OTCMKTS:HALB) has been one of the healthcare-related companies to have come into focus among investors frequently due to some of the milestones it has hit in its research activities.
On Tuesday, HALB stock surged 8.42% to $0.0110 with 3.48 million shares, compared to its average volume of 1.2 million shares. The stock moved within a range of $0.0104 – 0.0129 after opening trade at $0.0110.
Yesterday, the company was in the news after it made another major announcement of the same nature and that led to considerable action in its stock. The trading volumes in the stock went up considerably and it ended up with gains of as much as 8.4%. In such a situation, it may be a good idea for investors to consider taking a closer look at the latest developments.
The company announced yesterday that it had been successful in eliminating as much as 90% of a range of antibiotic-resistant bacteria from a buffer solution in-vitro. The elimination of the bacteria was achieved by deploying a solitary designer monoclonal antibody that had been conjoined to a metallic nanoparticle. The nanoparticle, in turn, attached itself to the bacteria.
Once the bacteria had been separated, the combination of the nanoparticle-bacteria-antibody had been exposed to laser energy. It was a major new breakthrough for the company considering the fact that the types of antibiotic bacteria that it had managed to eliminate had the capability of causing serious diseases in human beings.
It should be noted that some of the diseases that may be caused by these types of bacteria include meningitis and curing sepsis among others. Hence, it may be said that it was a major new breakthrough for Halberd and could lead to a considerable long-term boost for the company.
During the course of the lab testing, it was found that the procedure deployed by the company could eliminate the bacteria types in a matter of 20 minutes. It may be a good time to keep an eye on the Halberd stock.